AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

K-Mox-CV Dry Syrup

Prescription Icon
Prescription Required

Marketer

Kriti Lifesciences

Salt Composition

Amoxycillin (200mg) + Clavulanic Acid (28.5mg)

Overview K-Mox-CV Dry Syrup

Cefixime dry syrup is an antibiotic combating bacterial infections affecting the ears, nose, throat, respiratory system, teeth, skin, and urinary tract. Its effectiveness extends to bacteria resistant to other treatments, including some tuberculosis strains. Administer this syrup to your child with or without food; however, giving it with food enhances absorption and minimizes stomach discomfort. The prescribed dosage (two to three times daily) varies depending on infection severity, type, and your child's weight and age. Always follow the prescribed dosage, timing, and administration method. If your child vomits within 30 minutes, allow them to settle before repeating the dose; avoid doubling doses. Potential side effects include vomiting, diarrhea, nausea, stomach pain, and allergic reactions. While these typically resolve, persistent or bothersome side effects necessitate immediate consultation with your child's physician. Provide your child's complete medical history to the doctor, including any prior allergies, cardiac conditions, blood disorders, birth defects, respiratory issues, gastrointestinal problems, skin conditions, liver problems, or kidney dysfunction. This comprehensive information aids in precise dosage adjustments and optimal treatment planning.

Primary Ingredients of K-Mox-CV Dry Syrup

The provided text is "undefined," therefore, no rewriting is possible.

Uses of K-Mox-CV Dry Syrup

Combating Drug-Resistant Tuberculosis and Bacterial Infections

Major Benefits of K-Mox-CV Dry Syrup:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Always consult the product label for usage details prior to administration. Use a measuring cup for accurate oral dosing. Ensure thorough shaking before each use. Administer K-Mox-CV Dry Syrup with food.

Common Side effects of K-Mox-CV Dry Syrup:

  • Abdominal pain
  • Allergy
  • Vomiting
  • Nausea
  • Diarrhea
  • Mucocutaneous candidiasis

How to use K-Mox-CV Dry Syrup:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Always consult the product label for usage guidelines prior to administration. Use a measuring device for accurate dosing and ingest orally. Ensure thorough shaking before each use. K-Mox-CV Dry Syrup should be consumed with a meal.

How K-Mox-CV Dry Syrup works:

K-Mox-CV Dry Syrup is a dual-action antibiotic containing amoxycillin and clavulanic acid. Amoxycillin disrupts bacterial cell wall synthesis, a crucial process for bacterial survival. Simultaneously, clavulanic acid neutralizes beta-lactamase, an enzyme produced by antibiotic-resistant bacteria. This synergistic action makes K-Mox-CV Dry Syrup effective against a wide range of infections.

SAFETY ADVICE

KidneyKidneyCAUTION

Patients with kidney impairment should use K-Mox-CV Dry Syrup judiciously, potentially requiring dosage modification. Physician consultation is advised. Neonates and infants also necessitate a lower dose because of their immature renal systems.

LiverLiverCAUTION

Patients with liver impairment should use K-Mox-CV Dry Syrup judiciously, potentially requiring dosage modification. Physician consultation is advised. Routine liver function testing is recommended during treatment.

What if you forget to take K-Mox-CV Dry Syrup :

If you forget a dose, administer it immediately upon recollection unless your physician instructs differently. However, omit the missed dose if the next scheduled dose is imminent. Avoid doubling the dose to compensate; adhere to the recommended medication schedule.

Facts to Know About K-Mox-CV Dry Syrup

LabelValue
Developing Habits No.
Treatment Category Infectious Disease Treatments

FAQs on K-Mox-CV Dry Syrup

K-Mox-CV Dry Syrup may interact with other medications. Inform your child's doctor about all medications your child is taking before administering K-Mox-CV Dry Syrup, and always consult your child's doctor before giving them any new medicine.
Generally, antibiotics don't interact negatively with vaccines or cause adverse reactions in recently vaccinated children. However, vaccination should be postponed for children receiving antibiotics until their illness resolves. Once your child recovers, vaccination can proceed.
Regular kidney and liver function tests may be monitored during extended treatment to assess your child's progress.
Exceeding the recommended dosage of this medication raises the risk of side effects. If your child's symptoms worsen, consult your doctor.
Continue giving your child this medicine for the entire prescribed course, even if symptoms improve. Stopping early might not fully cure the infection, and the medicine may still be working.
K-Mox-CV Dry Syrup can cause diarrhea as a side effect. This is because, while it eliminates harmful bacteria, it can also affect beneficial gut bacteria. If your child experiences diarrhea, ensure they drink plenty of fluids. Contact your doctor if diarrhea continues or you see dehydration symptoms such as decreased urination and dark, strong-smelling urine. Never administer other medications without consulting a doctor.
Bacterial infections rarely follow viral infections; antibiotics are ineffective against viruses and may harm your child. Consult your doctor before using antibiotics.
A yellow or green nasal discharge doesn't necessitate antibiotics. This color change is a normal part of a common cold, as mucus thickens over time. Symptoms typically resolve within 7-10 days.
Contact your child's doctor immediately if they develop serious allergic reactions (like breathing difficulties or rashes), gastrointestinal problems (such as diarrhea), or signs of liver damage (including weakness, pallor, and vomiting). While uncommon, these side effects require prompt medical attention.
K-Mox-CV Dry Syrup
59